On January 30, 2025, the US FDA approved Journavx (suzetrigine) 50mg oral tablets to use in the treatment of moderate to severe acute pain, making it the first non-opioid analgesic of its class to ...
A reliable method to treat post-amputation pain remains elusive, but a new Northwestern Medicine study conducted in collaboration with Ukrainian physicians suggests that hydrodissection -- a simple ...
Current asthma treatments don't work in all patients, and they don't provide long-term relief from potentially deadly asthma ...
Researchers say an epidural injection can provide relief for chronic back pain but it's not a permanent solution.
A reliable method to treat post-amputation pain remains elusive, but a new Northwestern Medicine study conducted in ...
The FDA approved the first drug in its class that targets moderate to severe acute pain in adults, without being addictive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback